In our study, overexpression of SELENBP1 markedly inhibited the proliferation, migration, and invasion of NSCLC cells in vitro, and further experiments in vivo confirmed that overexpression of SELENBP1 could also inhibit the growth of tumor cells. Here, SELENBP1 is linked to non-small cell lung carcinoma.